clinical coagulation test
Jump to navigation
Jump to search
Differential diagnosis
- prolonged prothrombin time, normal aPTT
- normal prothrombin time, prolonged aPTT
- factor VIII deficiency
- factor IX deficiency
- factor XI deficiency
- factor XII deficiency
- von Wiilibrand's disease (if factor VIII low)
- heparin
- prolonged prothrombin time, prolonged aPTT
- normal prothrombin time, normal aPTT
- platelet dysfunction (acquired or congenital)
- von Willebrand's disease (factor VIII not too low)
- scurvy
- Ehlers-Danlos syndrome
- hereditary hemorrhagic telangiectasia
- factor XIII deficiency
More general terms
More specific terms
- activated protein C (APC) resistance assay
- argatroban in plasma
- clotting time
- coagulation factor assay
- coagulation factor II inhibitor in plasma
- coagulation factor IX inhibitor in plasma
- coagulation factor V inhibitor in plasma
- coagulation factor VII inhibitor in plasma
- coagulation factor VIII inhibitor in plasma
- coagulation factor X inhibitor in plasma; anti-factor Xa heparin assay
- coagulation factor XI inhibitor in plasma
- coagulation factor XII inhibitor in plasma
- coagulation factor XIII inhibitor in plasma
- coagulation/fibrinolysis assay/screen (viscoelastic clot assessment)
- factor IX activity in plasma
- factor IX antigen in plasma
- factor V activity in plasma
- factor V antigen in plasma
- factor VII activity in plasma
- factor VII antigen in plasma
- factor VIIa activity in plasma
- factor VIII activity in plasma
- factor VIII antigen in plasma
- factor X activity in plasma
- factor XI activity in plasma
- factor XI antigen in plasma
- factor XII activity in plasma
- factor XII antigen in plasma
- factor XIII activity in plasma
- factor XIII antigen in plasma
- factor XIII coagulum dissolution in plasma
- fibrin degradation products in plasma; fibrin split products in plasma (FDP, FSP)
- fibrin soluble in serum/plasma
- fibrinogen Ag in plasma
- fibrinolysis inhibitor in plasma
- fibrinopeptide A antigen in body fluid
- fibrinopeptide B in serum
- heparin cofactor II in plasma
- heparin-induced platelet aggregation
- high molecular weight kininogen in plasma (Fitzgerald factor assay)
- International normalized ratio (INR)
- kallikrein in plasma
- LMW heparin in body fluid
- low molecular weight kininogen in plasma
- lupus anticoagulant in plasma
- maximum clot lysis
- maxium clot firmness
- partial thromboplastin time (PTT)
- plasma mixing studies
- plasminogen activator urokinase type meausurement
- plasminogen activity (plasmin) in plasma
- plasminogen antigen in plasma
- platelet factor 3 in plasma
- platelet factor 4 Ag in plasma
- platelet factor 4 in plasma
- platelet function in blood
- prekallikrein (Fletcher Factor) in plasma
- prothrombin antibody in serum/plasma
- prothrombin fragment 1.2 Ag in serum/plasma
- prothrombin fragment 1.2 in serum/plasma
- prothrombin in plasma
- prothrombin time (PT)
- PTT circulating inhibitor in plasma
- serotonin release assay
- thrombin time (TT)
- thrombin-antithrombin complex in plasma
- thromboglobulin in plasma
- thrombopoietin in plasma
- tissue thromboplastin inhibition test
- von Willebrand factor (vWF) multimers in plasma
- von Willebrand factor (vWF)-cleaving protease (ADAMTS-13) in plasma
- von Willebrand factor activity in plasma
- von Willebrand factor antigen in plasma
- von Willebrand factor collagen-binding ratio
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018